MONTRÉAL, April 08, 2024 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) announces that it has completed the sale of…
MONTRÉAL, Québec, April 03, 2024 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) is pleased to announce that at an…
MONTRÉAL, March 22, 2024 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the…
MONTRÉAL, March 14, 2024 -- IBEX Technologies Inc. announces that it has filed an addendum to its management proxy circular dated February 23, 2024 for the annual and special meeting of...
- Shareholders holding an aggregate of 47.15% of IBEX’s outstanding shares have entered into Support and Voting Agreements with the purchaser - IBEX Board unanimously recommends that shareholders...
MONTREAL, July 17, 2023 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today announced that the TSX Venture Exchange…
The enzyme contract manufacturing market dynamics are anticipated to change in the coming years owing to the burgeoning pharmaceutical and healthcare...